IMNM Stock Analysis: Buy, Sell, or Hold?
IMNM - Immunome, Inc.
$24.62
-0.45 (-1.79%)
▼
5d:
-4.83%
30d:
+16.24%
90d:
+56.22%
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 18, 2026
Smart Money Accumulation
IMNM is down 4.8% this week, but smart money is accumulating calls. Top strike: $22 2026-04-17 with 286 OI. Call ratio: 93% View Scanner →
Strength: 6.7/10
Get Alerted When IMNM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IMNM shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: IMNM shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: IMNM is currently trading at $24.62, which is considered extended relative to its 30-day fair value range of $20.05 to $23.76.
Technical Outlook: Technically, IMNM is in a strong uptrend. Immediate support is located at $21.39, while resistance sits at $26.62.
Market Sentiment: IMNM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $34.50 (+40.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IMNM is in a strong uptrend. Immediate support is located at $21.39, while resistance sits at $26.62.
Market Sentiment: IMNM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $34.50 (+40.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$20.05 -
$23.76
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 40.1% below Wall St target ($34.50)
Fair Price Analysis
30-Day Fair Range
$20.05 -
$23.76
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$21.39
Resistance Level
$26.63
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-10.02
Wall Street Target
$34.50
(+40.1%)
Revenue Growth (YoY)
69.8%
Last updated: February 02, 2026 2:39 AM ET
Data refreshes hourly during market hours. Next update: 3:39 AM
Data refreshes hourly during market hours. Next update: 3:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMNM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$514 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$847 | 52 HOLD |
Advanced IMNM Option Strategies
Professional options setups generated by AI based on today's IMNM price and gamma walls.
